Clinical Trial: Randomized, Controlled, Open-label Clinical Study on the Effects of Low-dose Hormone Combined with Colchicine on Late Lumen Loss and Inflammatory Markers in Patients with Early-onset Coronary Artery Disease with Triple Lesions (COLCHI-CORT Trial) (China)

Posted On: 2026-09-23

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Randomized, Controlled, Open-label Clinical Study on the Effects of Low-dose Hormone Combined with Colchicine on Late Lumen Loss and Inflammatory Markers in Patients with Early-onset Coronary Artery Disease with Triple Lesions (COLCHI-CORT Trial)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133118

Registration Time: 2026/09/22

Type: Interventional study

Primary Sponsor: Dongguan People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339692

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Randomized, Controlled, Open-label Clinical Study on the Effects of Low-dose Hormone Combined with Colchicine on Late Lumen Loss and Inflammatory Markers in Patients with Early-onset Coronary Artery Disease with Triple Lesions (COLCHI-CORT Trial) (China)